Race Oncology Ltd.

Race Oncology Ltd.
Stock Exchange Australian Stock Exchange
EPS
AUD0.07
Market Cap
AUD4.11 M
Shares Outstanding
82.24 M
Public Float
65.63 M

Profile

Address
710 Collins Street
Docklands Victoria (VIC) 3008
Australia
Employees -
Website http://www.raceoncology.com
Updated 07/08/2019
Race Oncology Ltd is a pharmaceutical company, whose business model is to pursue later stage drug assets, principally in the cancer field. Its first important asset is a chemotherapy drug, called Bisantrene, which is used as the first line of treatment for Acute Myeloid Leukaemia and many other cancers. The company was founded on February 15, 2011 and is headquartered in Docklands, Australia.

Financials

View All
Created with Highcharts 5.0.14Race Oncology Ltd.Net Income. Fiscal year is July-June. All values AUD Thousands.929287873173174 1714 1716 3066 3062014201520162017201802k4k6k8k

William J. Garner
Chairman
Peter Laurence Molloy
Chief Executive Officer, Director & MD